132 related articles for article (PubMed ID: 21798680)
1. Influence of multiple injections of human chorionic gonadotropin (hCG) on urine and serum endogenous steroids concentrations.
Strahm E; Marques-Vidal P; Pralong F; Dvorak J; Saugy M; Baume N
Forensic Sci Int; 2011 Dec; 213(1-3):62-72. PubMed ID: 21798680
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant human LH and hCG on serum and urine LH and androgens in men.
Handelsman DJ; Goebel C; Idan A; Jimenez M; Trout G; Kazlauskas R
Clin Endocrinol (Oxf); 2009 Sep; 71(3):417-28. PubMed ID: 19170708
[TBL] [Abstract][Full Text] [Related]
3. Doping control of testosterone and human chorionic gonadotrophin: a case study.
de Boer D; de Jong EG; van Rossum JM; Maes RA
Int J Sports Med; 1991 Feb; 12(1):46-51. PubMed ID: 2030059
[TBL] [Abstract][Full Text] [Related]
4. Influence of multiple human chorionic gonadotropin administrations on serum and urinary steroid Athlete Biological Passport profiles in males.
Goodrum JM; Moore C; Crouch AK; Eichner D; Miller GD
Drug Test Anal; 2023; 15(11-12):1371-1381. PubMed ID: 37749856
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of two immunoassays for the measurement of human chorionic gonadotropin in urine for anti-doping purposes.
Robinson N; Sottas PE; Saugy M
Clin Lab; 2010; 56(5-6):197-206. PubMed ID: 20575467
[TBL] [Abstract][Full Text] [Related]
6. Comparison of newly developed immuno-MS method with existing DELFIA(®) immunoassay for human chorionic gonadotropin determination in doping analysis.
Lund H; Snilsberg AH; Halvorsen TG; Hemmersbach P; Reubsaet L
Bioanalysis; 2013 Mar; 5(5):623-30. PubMed ID: 23425277
[TBL] [Abstract][Full Text] [Related]
7. Analysis of human chorionic gonadotropin (hCG): application of routine immunological methods for initial testing and confirmation analysis in doping control.
Kuuranne T; Ahola L; Pussinen C; Leinonen A
Drug Test Anal; 2013 Aug; 5(8):614-8. PubMed ID: 23303576
[TBL] [Abstract][Full Text] [Related]
8. Immunoprocedures for detecting human chorionic gonadotropin: clinical aspects and doping control.
Stenman UH; Unkila-Kallio L; Korhonen J; Alfthan H
Clin Chem; 1997 Jul; 43(7):1293-8. PubMed ID: 9216477
[TBL] [Abstract][Full Text] [Related]
9. Urine reference intervals for human chorionic gonadotropin (hCG) isoforms by immunoextraction-tandem mass spectrometry to detect hCG use.
Butch AW; Ahrens BD; Avliyakulov NK
Drug Test Anal; 2018 Jun; 10(6):956-960. PubMed ID: 29098788
[TBL] [Abstract][Full Text] [Related]
10. A study of the endocrine manifestations of hepatic cirrhosis.
Baker HW; Burger HG; de Kretser DM; Dulmanis A; Hudson B; O'Connor S; Paulsen CA; Purcell N; Rennie GC; Seah CS; Taft HP; Wang C
Q J Med; 1976 Jan; 45(177):145-78. PubMed ID: 769039
[TBL] [Abstract][Full Text] [Related]
11. Sports drug testing using immuno-MS: clinical study comprising administration of human chorionic gonadotropin to males.
Lund H; Snilsberg AH; Paus E; Halvorsen TG; Hemmersbach P; Reubsaet L
Anal Bioanal Chem; 2013 Feb; 405(5):1569-76. PubMed ID: 23203507
[TBL] [Abstract][Full Text] [Related]
12. Short-term human chorionic gonadotropin-induced testosterone rise does not modify leptin levels in eugonadal men.
Panidis D; Koliakos G; Kourtis A; Rousso D; Mavromatidis G; Triantos A; Kalahanis I
Gynecol Endocrinol; 2002 Feb; 16(1):75-81. PubMed ID: 11915586
[TBL] [Abstract][Full Text] [Related]
13. Detection and effects on serum and urine steroid and LH of repeated GnRH analog (leuprolide) stimulation.
Handelsman DJ; Idan A; Grainger J; Goebel C; Turner L; Conway AJ
J Steroid Biochem Mol Biol; 2014 May; 141():113-20. PubMed ID: 24495617
[TBL] [Abstract][Full Text] [Related]
14. Secretion and excretion of human chorionic gonadotropin during early pregnancy.
Lohstroh PN; Overstreet JW; Stewart DR; Nakajima ST; Cragun JR; Boyers SP; Lasley BL
Fertil Steril; 2005 Apr; 83(4):1000-11. PubMed ID: 15820813
[TBL] [Abstract][Full Text] [Related]
15. Effect of administration of human chorionic gonadotrophin on criteria used to assess testosterone administration in athletes.
Cowan DA; Kicman AT; Walker CJ; Wheeler MJ
J Endocrinol; 1991 Oct; 131(1):147-54. PubMed ID: 1744555
[TBL] [Abstract][Full Text] [Related]
16. Performance characteristics of two immunoassays for the measurement of urinary luteinizing hormone.
Robinson N; Saudan C; Sottas PE; Mangin P; Saugy M
J Pharm Biomed Anal; 2007 Jan; 43(1):270-6. PubMed ID: 16884883
[TBL] [Abstract][Full Text] [Related]
17. Individual deviations in human chorionic gonadotropin concentrations during pregnancy.
Cole LA
Am J Obstet Gynecol; 2011 Apr; 204(4):349.e1-7. PubMed ID: 21324434
[TBL] [Abstract][Full Text] [Related]
18. Statistical discrimination of steroid profiles in doping control with support vector machines.
Van Renterghem P; Sottas PE; Saugy M; Van Eenoo P
Anal Chim Acta; 2013 Mar; 768():41-8. PubMed ID: 23473248
[TBL] [Abstract][Full Text] [Related]
19. Urine stability and steroid profile: towards a screening index of urine sample degradation for anti-doping purpose.
Mazzarino M; Abate MG; Alocci R; Rossi F; Stinchelli R; Molaioni F; de la Torre X; Botrè F
Anal Chim Acta; 2011 Jan; 683(2):221-6. PubMed ID: 21167974
[TBL] [Abstract][Full Text] [Related]
20. Screening for testosterone abuse in male athletes using the measurement of urinary LH, a revision of the paradigm.
Goebel C; Howe CJ; Ho KK; Nelson A; Kazlauskas R; Trout GJ
Drug Test Anal; 2009 Nov; 1(11-12):511-7. PubMed ID: 20355166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
